GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agios Pharmaceuticals Inc (MEX:AGIO) » Definitions » E10

Agios Pharmaceuticals (MEX:AGIO) E10 : MXN-27.32 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Agios Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Agios Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2024 was MXN-30.961. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-27.32 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-09-26), Agios Pharmaceuticals's current stock price is MXN397.93. Agios Pharmaceuticals's E10 for the quarter that ended in Jun. 2024 was MXN-27.32. Agios Pharmaceuticals's Shiller PE Ratio of today is .


Agios Pharmaceuticals E10 Historical Data

The historical data trend for Agios Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agios Pharmaceuticals E10 Chart

Agios Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -40.02 -46.39 -48.24

Agios Pharmaceuticals Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.68 -45.22 -48.24 -38.65 -27.32

Competitive Comparison of Agios Pharmaceuticals's E10

For the Biotechnology subindustry, Agios Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agios Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Agios Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Agios Pharmaceuticals's Shiller PE Ratio falls into.



Agios Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Agios Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-30.961/132.5538*132.5538
=-30.961

Current CPI (Jun. 2024) = 132.5538.

Agios Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201409 1.343 100.428 1.773
201412 -11.210 99.070 -14.999
201503 -1.982 99.621 -2.637
201506 -13.337 100.684 -17.559
201509 -18.081 100.392 -23.874
201512 -18.571 99.792 -24.668
201603 -10.501 100.470 -13.854
201606 -27.185 101.688 -35.437
201609 -31.517 101.861 -41.014
201612 -27.627 101.863 -35.951
201703 -29.373 102.862 -37.852
201706 -32.175 103.349 -41.267
201709 -28.855 104.136 -36.729
201712 -35.547 104.011 -45.302
201803 -29.613 105.290 -37.281
201806 -23.383 106.317 -29.153
201809 -30.489 106.507 -37.945
201812 -31.023 105.998 -38.795
201903 -30.843 107.251 -38.120
201906 -35.921 108.070 -44.059
201909 -35.733 108.329 -43.724
201912 -30.176 108.420 -36.893
202003 -13.834 108.902 -16.839
202006 -30.238 108.767 -36.851
202009 -31.590 109.815 -38.131
202012 -28.048 109.897 -33.831
202103 550.885 111.754 653.414
202106 -28.067 114.631 -32.455
202109 -32.077 115.734 -36.739
202112 -35.694 117.630 -40.223
202203 -34.645 121.301 -37.859
202206 -33.798 125.017 -35.836
202209 -29.971 125.227 -31.725
202212 13.062 125.222 13.827
202303 -26.497 127.348 -27.580
202306 -25.887 128.729 -26.656
202309 -28.567 129.860 -29.160
202312 -29.196 129.419 -29.903
202403 -24.065 131.776 -24.207
202406 -30.961 132.554 -30.961

Add all the adjusted EPS together and divide 10 will get our e10.


Agios Pharmaceuticals  (MEX:AGIO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Agios Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Agios Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Agios Pharmaceuticals Business Description

Traded in Other Exchanges
Address
88 Sidney Street, Cambridge, MA, USA, 02139
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Agios Pharmaceuticals Headlines